drugset / Trial / NCT06922045
Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor
Timeline
- Start
- 2025-03-26
- Primary completion
- 2026-09
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bemiltenase alfa | Protein / enzyme biologic | — | — |